nitroaspirin has been researched along with thromboxane b2 in 9 studies
| Studies (nitroaspirin) | Trials (nitroaspirin) | Recent Studies (post-2010) (nitroaspirin) | Studies (thromboxane b2) | Trials (thromboxane b2) | Recent Studies (post-2010) (thromboxane b2) |
|---|---|---|---|---|---|
| 127 | 9 | 8 | 7,483 | 715 | 485 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 7 (77.78) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bonapace, S; Degan, M; Fontana, L; Gaino, S; Lechi, A; Lechi, C; Minuz, P; Tommasoli, R; Zuliani, V | 1 |
| Degan, M; Gaino, S; Lechi, A; Meneguzzi, A; Minuz, P; Santonastaso, CL; Soldato, PD; Zuliani, V | 1 |
| Del Soldato, P; Miller, AM; Wainwright, CL; Work, LM | 1 |
| del Soldato, P; Fiorucci, S; Lechi, A; Mencarelli, A; Meneguzzi, A; Minuz, P; Morelli, A | 1 |
| Del Soldato, P; Faccino, RM; Fiorucci, S; Gresele, P; Morelli, A; Santucci, L | 1 |
| Berti, F; Del Soldato, P; Manfredi, B; Polvani, G; Rossoni, G | 1 |
| del Soldato, P; Fiorucci, S; Lechi, A; Mencarelli, A; Meneguzzi, A; Minuz, P; Morelli, A; Renga, B | 1 |
| Corazzi, L; Corazzi, T; Gresele, P; Leone, M; Maucci, R | 1 |
| Cardona, F; Derhaschnig, U; Jilma, B; Marsik, C; Minuz, P; Schweeger-Exeli, I | 1 |
3 trial(s) available for nitroaspirin and thromboxane b2
| Article | Year |
|---|---|
Gastrointestinal safety of NO-aspirin (NCX-4016) in healthy human volunteers: a proof of concept endoscopic study.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cardiotonic Agents; Digestive System; Double-Blind Method; Endoscopy, Gastrointestinal; Female; Gastric Mucosa; Humans; Intestinal Mucosa; Male; Pilot Projects; Placebos; Platelet Aggregation; Thromboxane B2 | 2003 |
Co-administration of nitric oxide-aspirin (NCX-4016) and aspirin prevents platelet and monocyte activation and protects against gastric damage induced by aspirin in humans.
Topics: Administration, Oral; Adult; Aspirin; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Duodenum; Flow Cytometry; Gastric Mucosa; Humans; Intestinal Mucosa; Male; Monocytes; Platelet Activation; Platelet Aggregation Inhibitors; Reference Values; Single-Blind Method; Stomach; Thromboxane A2; Thromboxane B2 | 2004 |
Effects of aspirin and NO-aspirin (NCX 4016) on platelet function and coagulation in human endotoxemia.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Blood Coagulation; Blood Platelets; Double-Blind Method; Endotoxemia; Endotoxins; Humans; Male; Platelet Activation; Thromboxane B2; Young Adult | 2010 |
6 other study(ies) available for nitroaspirin and thromboxane b2
| Article | Year |
|---|---|
In vitro study of the anti-aggregating activity of two nitroderivatives of acetylsalicylic acid.
Topics: Arachidonic Acid; Aspirin; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Humans; In Vitro Techniques; Nitric Oxide; Platelet Aggregation; Platelet Aggregation Inhibitors; Thrombin; Thromboxane A2; Thromboxane B2 | 1996 |
NCX4016 (NO-Aspirin) has multiple inhibitory effects in LPS-stimulated human monocytes.
Topics: Aspirin; Cyclic GMP; Dose-Response Relationship, Drug; Enzyme Inhibitors; Fibrinolytic Agents; Guanylate Cyclase; Humans; Interleukin-6; Lipopolysaccharides; Monocytes; Nitric Oxide; Oxadiazoles; Quinoxalines; Thromboplastin; Thromboxane B2; Tumor Necrosis Factor-alpha | 2001 |
NCX4016 (NO-aspirin) reduces infarct size and suppresses arrhythmias following myocardial ischaemia/reperfusion in pigs.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arrhythmias, Cardiac; Aspirin; Coronary Disease; Endothelium, Vascular; Hemodynamics; Leukocytes; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Platelet Aggregation; Swine; Thromboxane B2; Ventricular Fibrillation | 2002 |
NCX-4016 (NO-aspirin) inhibits lipopolysaccharide-induced tissue factor expression in vivo: role of nitric oxide.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Blotting, Western; Cyclooxygenase 2; Cysteine Proteinase Inhibitors; Drug Administration Schedule; Flow Cytometry; Gastric Mucosa; Interleukin-1; Isoenzymes; Isosorbide Dinitrate; Male; Monocytes; Nitric Oxide; Platelet Aggregation Inhibitors; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Thromboplastin; Thromboxane B2; Tumor Necrosis Factor-alpha | 2002 |
Nitric oxide-releasing aspirin inhibits vasoconstriction in perfused tail artery of normotensive and spontaneously hypertensive rats.
Topics: Animals; Arteries; Aspirin; Blood Pressure; Cyclic GMP; Dose-Response Relationship, Drug; In Vitro Techniques; Nitrates; Nitric Oxide Donors; Nitrites; Perfusion; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Tail; Thromboxane B2; Time Factors; Vasoconstriction | 2003 |
Direct and irreversible inhibition of cyclooxygenase-1 by nitroaspirin (NCX 4016).
Topics: Animals; Aspirin; Blood Platelets; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Dialysis; Dinoprostone; Dose-Response Relationship, Drug; Hemostatics; Humans; Kinetics; Molecular Structure; Monocytes; Platelet Aggregation Inhibitors; Sheep; Spectrophotometry; Thrombin; Thromboxane B2; Time Factors | 2005 |